Pacira | PCRX - 税前利润

金融业

USD

USD 1.21B

现金及等价物

USD 144.31M

USD 50.74M

USD 514.96M

USD 108.79M

USD 367.66M

USD 4.63M

USD 40.24M

790

EPS每股收益

USD 0.6

股本和储备

USD 653.89M

USD 126.64M

债务利息支出

USD 3.7M

USD 2.3M

USD 367.66M

USD 1.05B

USD 2.92M

USD 172.75M

USD 4.63M

普通股股本

USD 39.31M

38.58

USD 571K

USD 177M

销售和管理费用

USD 83.88M

USD 150.37M

贸易债权人

USD 14.01M

应收帐款人

USD 125.64M

	税前利润	更改		日
Assertio Holdings	USD -2.88M		648K	2024-09
Astellas Pharma	JPY 48.02B		85.93B	2026-03
Bristol-Myers Squibb	USD 1.47B		1.64B	2025-12
Cara Therapeutics	USD -4.91M		3.17M	2025-03
Coherus Biosciences	USD -46.35M		90.86M	2025-12
Heron Therapeutics	USD -2.95M		14.54M	2025-12
Ironwood Pharmaceuticals	USD 68.02M		30.2M	2025-09
J&J	USD 7.82B		2.86B	2026-03
Ligand Pharmaceuticals	USD 56.78M		84.36M	2025-12
Nektar Therapeutics	USD -34.7M		2.35M	2025-12
Novo Nordisk	DKK 33.8B		3.23B	2025-06
Omeros	USD -65.12M		21.27M	2024-06
Pacira	USD 571K		8.95M	2025-12
Perrigo	USD -1.33B		1.35B	2025-12
Pfizer	USD 5.18B		6.82B	2026-03
Supernus Pharmaceuticals	USD -5.95M		4.04M	2026-03
Teva Pharmaceutical Industries	USD 753M		662M	2026-03
Xeris Pharmaceuticals	USD 11.08M		10.46M	2025-12
Xoma	USD 15.98M		24.58M	2024-06
Zoetis	USD 761M		126M	2025-12